These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
638 related articles for article (PubMed ID: 26058997)
1. [The subcutaneous cardioverter-defibrillator: When less is more]. Kuschyk J; Rudic B; Akin I; Borggrefe M; Röger S Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):123-8. PubMed ID: 26058997 [TBL] [Abstract][Full Text] [Related]
2. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327 [TBL] [Abstract][Full Text] [Related]
3. Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs). Cappato R; Ali H Int J Cardiol; 2017 Jun; 237():38-41. PubMed ID: 28377192 [TBL] [Abstract][Full Text] [Related]
4. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death. Sanghera R; Sanders R; Husby M; Bentsen JG Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791 [TBL] [Abstract][Full Text] [Related]
5. The subcutaneous implantable cardioverter-defibrillator in review. Kamp NJ; Al-Khatib SM Am Heart J; 2019 Nov; 217():131-139. PubMed ID: 31654943 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement. Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043 [TBL] [Abstract][Full Text] [Related]
9. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias. Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985 [TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
11. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach. Schneider AE; Burkhart HM; Ackerman MJ; Dearani JA; Wackel P; Cannon BC Heart Rhythm; 2016 Sep; 13(9):1905-12. PubMed ID: 27321244 [TBL] [Abstract][Full Text] [Related]
12. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator. Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey. Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525 [TBL] [Abstract][Full Text] [Related]